BAYZED HEALTH (02609) has announced board changes following its Annual General Meeting.
Zhao Yongkai (Mr. Zhao) did not stand for re-election as an executive director as he wishes to devote more time to other business pursuits. His tenure concluded at the close of the AGM.
Consequently, with Mr. Zhao's retirement from the board, he also ceased to serve as the company's authorized representative for the purposes of Rule 3.05 of the Listing Rules following the AGM.
The board further announced that Dr. Chen Haoyang has been appointed as the authorized representative, effective June 16, 2026.
Following approval by shareholders at the AGM, Mr. Lü Chao has been appointed as an executive director, also effective from June 16, 2026.
Comments